Position in GILD
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$816,661
-$118,790 QoQ
Shares Held
6,464
-3.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,160
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 48%
Shared 52%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Belpointe Asset Management LLC holds $43,294,431 across 10 Drug Manufacturers - General names. GILD ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
46,672 | $11,744,542 | |
| 2 | LLY |
ELI LILLY & Co
|
7,399 | $8,874,583 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
125,071 | $7,206,591 | |
| 4 | JNJ |
Johnson & Johnson
|
16,266 | $4,131,076 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,259 | $3,888,281 | |
| 6 | PFE |
Pfizer Inc
|
156,552 | $3,769,772 | |
| 7 | AMGN |
Amgen Inc
|
6,723 | $2,434,532 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
6,464 | $816,661 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $816,661 | 6,464 | Shares | Other | 2026-07-31 | |
| 2026-03-31 | $935,451 | 6,712 | Shares | Other | 2026-04-28 | |
| 2025-12-31 | $749,941 | 6,110 | Shares | Other | 2026-01-27 | |
| 2025-09-30 | $629,481 | 5,671 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $614,995 | 5,547 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $832,195 | 7,427 | Shares | Other | 2025-05-20 | |
| 2024-12-31 | $787,638 | 8,527 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $343,240 | 4,094 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $901,741 | 13,143 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $806,189 | 11,006 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $846,392 | 10,448 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $850,194 | 11,345 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $594,440 | 7,713 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,857,449 | 22,387 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,545,795 | 29,654 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,204,060 | 35,728 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,228,683 | 36,057 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,894,255 | 31,863 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,655,508 | 22,800 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,421,796 | 20,355 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,430,841 | 20,779 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,219,826 | 18,874 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,280,613 | 21,981 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $845,671 | 13,383 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,011,068 | 13,141 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $1,447,353 | 19,360 | Shares | Sole | 2020-07-20 | |
| No filing history on record for this holder in this stock. | ||||||